Cargando…
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis
Odevixibat, an ileal bile acid transporter (IBAT) inhibitor, is effective for the treatment of pruritus in children diagnosed with progressive familial intrahepatic cholestasis (PFIC) type 1 and 2. There are no studies showing the efficacy of Odevixibat in children with different subtypes of PFIC. W...
Autores principales: | Pepe, Angela, Colucci, Angelo, Carucci, Martina, Nazzaro, Lucia, Bucci, Cristina, Ranucci, Giusy, Di Giorgio, Angelo, Vajro, Pietro, Mandato, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974160/ https://www.ncbi.nlm.nih.gov/pubmed/36865697 http://dx.doi.org/10.3389/fped.2023.1061535 |
Ejemplares similares
-
Odevixibat and partial external biliary diversion showed equal improvement of cholestasis in a patient with progressive familial intrahepatic cholestasis
por: Slavetinsky, Christoph, et al.
Publicado: (2020) -
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis
por: Thompson, Richard J., et al.
Publicado: (2023) -
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis
por: Colantuono, Rossella, et al.
Publicado: (2022) -
Cholestasis in Benign Recurrent Intrahepatic Cholestasis 2
por: Arthur Lorio, Eric, et al.
Publicado: (2020) -
Intrahepatic cholestasis of pregnancy
por: Pusl, Thomas, et al.
Publicado: (2007)